Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane

Measurement of tumour and normal tissue perfusion in vivo in cancer patients will aid the clinical development of antiangiogenic and antivascular agents. We investigated the potential antiangiogenic effects of the drug razoxane by measuring the changes in parameters estimated from H(2)(15)O and C(15...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, H, Yap, J T, Wells, P, Miller, M P, Propper, D, Price, P, Harris, A L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394254/
https://www.ncbi.nlm.nih.gov/pubmed/12865914
http://dx.doi.org/10.1038/sj.bjc.6601105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394254/
https://www.ncbi.nlm.nih.gov/pubmed/12865914
http://dx.doi.org/10.1038/sj.bjc.6601105

Ejemplares similares